Cardio Diagnostics Holdings, Inc.

US$1.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CDIOHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (66.29%)
Div yield —
ROE (93.55%)
Biotechnology
Beta (5Y) 2.27
PE TTM —
TSR TTM (59.13%)
Mkt cap US$4.886M
ROIC (55.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.01
21.66%
(31.39%)
Hold 4|3|7|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.03
0.03
0.03
4.51%
20.41%
30.39%
21.33%
Revenue$M
0.428
0.421
0.432
0.438
4.25%
0.79%
(1.68%)
2.05%
Peers (US$4.886M)
Cap (US$)
PE
4.878M
—
4.741M
—
4.895M
—
Capital
TTM
5Y
10Y
Leveragex
1.405
(0.134)
(0.106)
EBIT/Intx
0.537
0.669
0.448
Own earn%
(43.96)
29.71
32.39
Sh yield%
46.76
59.11
59.73
Owners
Insiders/Inst%
0.34
58.20
Short interest%
3.66
SBC / revenue%
2.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
18–25
$1 testx
—
Incr. ROIC%
13